Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats
Nutrients · 11.06.2023 · 15 (12) · 2710
DOI: 10.3390/nu15122710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.06.2023. Verfasst von Narathip Puttarat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Probiotics, Srinakharinwirot University, Bangkok 10110, Thailand. Hauptthemen laut MEDLINE: Hypercholesterolemia, Probiotics, Hyperlipidemias, Metabolic Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Research Fund, Srinakharinwirot University, Research and Researchers for Industries Program, Thailand Science Research and Innovation.
Abstract (Originalsprache)
Hypercholesterolemia is a significant risk factor for cardiovascular disease and metabolic disorders. Probiotics are the essential constituents of the gastrointestinal microbiota that provide health-promoting effects. Cholesterol-lowering activity is a specific property of probiotics, improving the cholesterol metabolism without adverse effects. Thus, the purpose of this study was to investigate the hypocholesterolemic effect of single and mixed cholesterol-lowering probiotic strains (including Limosilactobacillus reuteri TF-7, Enterococcus faecium TF-18, and Bifidobacterium animalis TA-1) in high-cholesterol diet (HCD)-induced hypercholesterolemic rats. The results showed that the administration of single probiotics contributed to a reduction in the body weight gain, visceral organ indexes, hyperlipidemia, and hepatic steatosis and also an improvement in the gastrointestinal microbiota. Besides the effect of single cholesterol-lowering probiotics, three probiotics strains could also synergize their hypocholesterolemic effect when administered simultaneously. These findings indicate that three cholesterol-lowering probiotic strains are suitable for development as probiotic supplements to reduce the risk of diseases caused by cholesterol and exert health benefits with synergistic effect when administered simultaneously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Probiotics, Srinakharinwirot University, Bangkok 10110, Thailand.
- Department of Microbiology, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.
- Department of Biomedical Science, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok 10300, Thailand.
- Faculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
- Research Unit for Sensor Innovation (RUSI), Burapha University, Chonburi 20131, Thailand.
ORCID-Profile: Marut Tangwattanachuleeporn
Förderung
- Thailand Research Fund
- Srinakharinwirot University
- Research and Researchers for Industries Program, Thailand Science Research and Innovation
Zitieren
APA
Puttarat, N., Kasorn, A., Vitheejongjaroen, P., Chantarangkul, C., Tangwattanachuleeporn, M., & Taweechotipatr, M. (2023). Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats. Nutrients, 15(12), 2710. https://doi.org/10.3390/nu15122710
Vancouver
Puttarat N, Kasorn A, Vitheejongjaroen P, Chantarangkul C, Tangwattanachuleeporn M, Taweechotipatr M. Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats. Nutrients. 2023;15(12):2710. doi:10.3390/nu15122710
BibTeX
@article{Puttarat2023,
author = {Puttarat, Narathip and Kasorn, Anongnard and Vitheejongjaroen, Porntipha and Chantarangkul, Chantanapa and Tangwattanachuleeporn, Marut and Taweechotipatr, Malai},
title = {Beneficial Effects of Indigenous Probiotics in High-Cholesterol Diet-Induced Hypercholesterolemic Rats},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {12},
pages = {2710},
doi = {10.3390/nu15122710}
}
EUVIMED